Clinical Trial to Evaluate the Safety and Efficacy of NTCB02-1 in Patients Who Require Parenteral Nutrition

Launched by YUHAN CORPORATION · Oct 2, 2024

Keywords

ClinConnect Summary

This clinical trial is studying a new treatment called NTCB02-1 for patients who need parenteral nutrition, which is a way to provide nutrients through an IV when a person cannot eat normally. The goal is to see if NTCB02-1 is safe and effective compared to another treatment, NTCB-C. The trial is open to adults aged 19 and older who are expected to need parenteral nutrition for more than three days. Participants will need to agree to join the study and sign a consent form.

If you decide to participate, you'll be randomly assigned to receive either NTCB02-1 or NTCB-C. The trial is taking place at multiple locations and is currently recruiting patients. It's important to note that some people may not be eligible to join, such as those who are expected to survive less than three days or have certain allergies. If you think you might qualify, or if you have any questions, you can talk to your healthcare provider for more information.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Those who are 19 years old or older at the screening visit
• • Patients are expected to require PN for more than 3 days
• • Patients who voluntarily signed the consent form
• Exclusion Criteria:
• • Patients are expected difficult to survive more than 3 days
• • Patients BMI is over 30 kg/m2
• • Patients having hypersensitivity to any peanut-, fish-, soy-, egg protein, or investigational drug
• • Patients with difficult central venous line
• • Patients judged to be unsuitable for this trial by investigators